HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VIP-helodermin receptors in the murine virus-induced T lymphoma cell line BL/VL3 recover less rapidly than beta-adrenoceptors after down regulation.

Abstract
The time course of recovery of beta-adrenergic and VIP/helodermin receptors after homologous and heterologous down regulation was studied in the murine lymphoma cell line BL/VL3, a neoplastic equivalent of immature T cells. The heterologous part of isoproterenol down regulation was rapidly reversed, even in the presence of cycloheximide, suggesting that down regulation was linked to ligand-receptor interaction and/or cyclic AMP increase. Homologous down regulations of beta-adrenoceptors and VIP/helodermin receptors were less rapidly reversible and depended on protein synthesis as they were inhibited by cycloheximide: beta-adrenoceptors recovered faster than VIP/helodermin receptors.
AuthorsC Damien, P Robberecht, J Abello, R Hooghe, J Christophe
JournalJournal of receptor research (J Recept Res) 1989-1990 Vol. 9 Issue 6 Pg. 441-9 ISSN: 0197-5110 [Print] United States
PMID2561794 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Intercellular Signaling Peptides and Proteins
  • Peptides
  • Receptors, Adrenergic, beta
  • Receptors, Gastrointestinal Hormone
  • Receptors, Vasoactive Intestinal Peptide
  • Vasoactive Intestinal Peptide
  • heliodermin
  • Adenylyl Cyclases
  • Isoproterenol
Topics
  • Adenylyl Cyclases (metabolism)
  • Animals
  • Cell Line, Transformed
  • Cell Transformation, Viral
  • Down-Regulation (physiology)
  • Intercellular Signaling Peptides and Proteins
  • Isoproterenol (pharmacology)
  • Lymphoma
  • Mice
  • Peptides (pharmacology)
  • Receptors, Adrenergic, beta (physiology)
  • Receptors, Gastrointestinal Hormone (physiology)
  • Receptors, Vasoactive Intestinal Peptide
  • T-Lymphocytes (metabolism)
  • Vasoactive Intestinal Peptide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: